Do not use in unhealthy animals.

Do not use in pregnant mares.

Minor transient increases in body temperature (<40°C) lasting 1-5 days and transient local reactions lasting 2-3 days (usually <4 cm) may be observed in approximately 20% of horses vaccinated. In one case a swelling of 20 cm and lasting 5 days was observed. Systemic reactions such as depression (1%), ocular and nasal discharge (8%), urticaria (<1%) and oedema of the legs, abdomen and scrotum (<1%) were observed.

Administration of a twofold overdose has no influence on the systemic reactions to vaccination. Local swellings (<4 cm in size) were observed in 80% of horses administered two doses of vaccine, these swellings were observed for one day only.

Animals that have received immunosuppressive drugs (e.g. glucocorticoids) should not be vaccinated until an interval of at least 4 weeks has elapsed.

No data are available on the safety and efficacy of concurrent administration of this vaccine with any other. It is therefore recommended that no other vaccines should be administered within 14 days before or after vaccination with Artervac.

Do not mix with other vaccines / immunological products.

In case of an allergic or anaphylactic reaction, administer adrenalin by intramuscular injection.

Vaccination does not prevent infection, nor does it have an effect on the shedding of EAV by previously infected carrier stallions.

The effect of the vaccine on the fertility of breeding stallions has not been investigated.

Equine viral arteritis (EVA) is a notifiable disease in the UK. Vaccinated horses will become seropositive and therefore it is recommended that they are blood tested prior to primary vaccination to demonstrate that they were previously seronegative. Details of blood testing and vaccination schedule should be recorded in the horse passport.

Zero days.

In case of accidental self-injection, seek medical advice immediately and show the package insert or the label to the physician.